iCellate Revenue and Competitors
Estimated Revenue & Valuation
- iCellate's estimated annual revenue is currently $2.1M per year.
- iCellate's estimated revenue per employee is $98,000
Employee Data
- iCellate has 21 Employees.
- iCellate grew their employee count by 5% last year.
iCellate's People
| Name | Title | Email/Phone |
|---|---|---|
1 | VP R&D-Operations, Laboratory Director | Reveal Email/Phone |
2 | Quality Director | Reveal Email/Phone |
3 | IT-Lead | Reveal Email/Phone |
4 | Senior Scientist | Reveal Email/Phone |
5 | Senior Scientist | Reveal Email/Phone |
6 | Senior Scientist and GeneMate Project Leader at iCellate Medical AB | Reveal Email/Phone |
7 | Genetic Counsellor | Reveal Email/Phone |
iCellate Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $14.1M | 101 | 5% | N/A | N/A |
#2 | $1.6M | 19 | -71% | N/A | N/A |
#3 | $212.8M | 1063 | 5% | $65M | N/A |
#4 | $6.8M | 54 | 8% | N/A | N/A |
#5 | $12.9M | 92 | 2% | $23.1M | N/A |
#6 | $1M | 12 | N/A | N/A | N/A |
#7 | $106.5M | 599 | -17% | $2.3M | N/A |
#8 | $35.6M | 231 | 6% | N/A | N/A |
#9 | $38.3M | 249 | 5% | N/A | N/A |
#10 | $45M | 299 | -4% | $102.6M | N/A |
What Is iCellate?
iCellate is a Swedish medtech company furthering cancer research and diagnostics. iCellate pioneers liquid biopsy through detection and analysis of circulating tumor cells (CTC) and circulating tumor DNA (ctDNA) and germline DNA (gDNA).
keywords:N/A
N/A
Total Funding
21
Number of Employees
$2.1M
Revenue (est)
5%
Employee Growth %
N/A
Valuation
N/A
Accelerator
iCellate News
2022-04-20 - Emerging Medical Device Technologies Market Size, Outlook And ...
... Abbott Laboratories, Alere Inc., Allergan Plc, Biotronik, Boston Scientific Corp., Harpoon Medical, Heartware, Helioscopie, Hologic, Icellate, Illumina,...
2022-04-20 - Noninvasive Cancer Diagnostics Market By Product Type, Share ...
... iCellate AB, Inivata, IV Diagnostics, and LCM GENECT Srl among others. Market Scenario of Noninvasive Cancer Diagnostics Market.
Other Companies in Solna
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | $2.4M | 23 | -66% | N/A |
#2 | $2M | 24 | 0% | N/A |
#3 | $3M | 27 | 42% | N/A |
#4 | $2.7M | 27 | -4% | N/A |
#5 | $5.4M | 27 | 0% | N/A |